ANXA5 and chronic kidney disease: Early research showed that, in platelet-free plasma from patients with CKD, there was an increase in CD 31+/Annexin V+endothelial microparticles (EMPs) accompanied by a decrease in the number of endothelial progenitor cells (EPCs) [37].